Xinjiang Zhichuang New Materials Co., Ltd. made a strategic appearance as an exhibitor at the 22nd CPHI & PMEC China Pharmaceutical Industry Exhibition held at Shenzhen Convention Center from December 14th to 16th. Representing Northwest China's fine chemical sector, the company showcased its core oxalate ester series through multidimensional engagements including technical demonstrations, onsite consultations, and B2B negotiations. These high-purity chemical intermediates attracted substantial attention from over 600 global pharmaceutical enterprises for their exceptional chemical stability (99.8% purity) and versatile applications in API synthesis.
During the exhibition, the technical team presented innovative catalytic application solutions of oxalate esters, establishing preliminary cooperation frameworks with industry leaders including Bayer and Shanghai Pharmaceuticals. Marketing Director Wang Lijun emphasized: "Our customized production services are creating unique competitive advantages. We aim to achieve 100 million RMB sales in South China within three years." The company distributed 500+ multilingual technical manuals and collected 230+ professional leads. This successful participation significantly enhanced brand visibility in pharmaceutical supply chains and laid groundwork for global market expansion, particularly targeting Southeast Asian and European markets through CPHI's international platform.
